Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dental implant surface put to the test in 30 patients

NCT ID NCT06651502

Disease control Sponsor: Harvard Medical School (HMS and HSDM) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new type of dental implant with a special surface (EK III NH) in 30 adults aged 20-80 who are missing teeth. Participants receive the implant and a temporary tooth replacement right away. Researchers will track how well the implant works over two years using dental exams and X-rays to check bone levels and stability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dental implant with new surface (EK III NH)
What this could lead to
If successful, this could show that the new implant surface helps keep bone stable around the implant, leading to better long-term outcomes for people with missing teeth.
What could go wrong
This is a small, early study with only 30 participants and no comparison group. Results may not apply to everyone, and the implant could fail or cause complications like infection or bone loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female, between 20-80 years of age, who request dental implant treatment options to replace missing teeth as part of comprehensive dental care * Subjects are willing to sign an informed consent, participate, and return for follow-up visits. * Subjects without significant medical history and currently not on medications that might complicate the results Exclusion Criteria: * Subjects who do not meet all the inclusion criteria or will not cooperate with the protocol schedule. * Subjects who received and failed a previously placed dental implant. * Subjects who require a bone and soft tissue grafting procedure prior to or at the time of the implant placement. * Subjects with significant untreated periodontal disease, caries, infection, or chronic inflammation in the oral cavity within two adjacent tooth positions of the clinical trial area. * Subjects who have used nicotine-containing products within three weeks prior to surgery. * Subjects who are insulin-dependent diabetic or if their Hgb1c levels \> 6.5%. * Subjects with a history of malignancy within the past five years (except for basal or squamous cell carcinoma of the skin or in situ cervical carcinoma). * Subjects who are nursing or pregnant. * Subjects who are presently taking medications (except estrogen/progesterone therapy) or those who are undergoing treatment that is known to affect bone turnover. * Subjects with diseases affecting bone metabolism (excluding idiopathic osteoporosis). * Subjects with a history of an autoimmune disease, documented allergy or multiple allergies to any component of the agents used in this study. * Acutely infected defect site.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Missing teeth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anodontia tooth agenesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Missing teeth

Contacts and locations

Locations

  • Harvard Dental Center

    Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.